Y
Yuli Cai
Researcher at Wuhan University
Publications - 17
Citations - 4027
Yuli Cai is an academic researcher from Wuhan University. The author has contributed to research in topics: Fatty liver & Proinflammatory cytokine. The author has an hindex of 11, co-authored 14 publications receiving 2884 citations. Previous affiliations of Yuli Cai include Texas A&M University & Huazhong University of Science and Technology.
Papers
More filters
Journal ArticleDOI
Mice lacking adenosine 2A receptor reveal increased severity of MCD-induced NASH
Jing Zhou,Honggui Li,Yuli Cai,Yuli Cai,Linqiang Ma,Linqiang Ma,Destiny Matthews,Bangchao Lu,Bangchao Lu,Bilian Zhu,Bilian Zhu,Yanming Chen,Xiaoxian Qian,Xiaoqiu Xiao,Qifu Li,Shaodong Guo,Yuqing Huo,Liang Zhao,Liang Zhao,Yanan Tian,Qingsheng Li,Chaodong Wu +21 more
TL;DR: Results suggest that A2AR disruption exacerbates MCD-induced NASH, which is attributable to, in large part, increased inflammatory responses in macrophages.
Journal ArticleDOI
Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits hyperglycemia-induced apoptosis in myocytes by suppressing receptor for advanced glycation end products expression.
TL;DR: The results from the present study suggest that the cardioprotective effect induced by EX-4, a GLP-1 receptor agonist, against diabetic cardiomyopathy may be associated with the inhibition of RAGE expression.
Journal ArticleDOI
Clinical Significance and Molecular Annotation of Cellular Morphometric Subtypes in Lower Grade Gliomas discovered by Machine Learning.
Xiao-Ping Liu,Xiaoqing Jin,Saman S. Ahmadian,Xu Yang,Sufang Tian,Yuli Cai,Kuldeep Chawla,Antoine M. Snijders,Yankai Xia,Paul J. van Diest,William A. Weiss,Jian-Hua Mao,Zhi-Qiang Li,Hannes Vogel,Hang Chang +14 more
TL;DR: A machine learning pipeline to extract CMBs from whole slide images of tissue histology is developed and validated a framework (CMS-ML) for CMS discovery in LGG associated with specific molecular alterations, immune micro-environment, prognosis, and treatment response.
Journal ArticleDOI
Epidemiological and clinical characteristics of 214 families with COVID-19 in Wuhan, China.
TL;DR: In this paper, the authors investigated the epidemiological dynamics, transmission patterns, and clinical outcomes of Coronavirus disease 2019 (COVID-19) in familial cluster patients in Wuhan, China.
Journal ArticleDOI
Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Obesity Mice Independent of AMPK
Shih Lung Woo,Ting Guo,Xin Guo,Honggui Li,Juan Zheng,Rachel Botchlett,Yuli Cai,Xiaodong Li,Qifu Li,Xiaoqiu Xiao,Yuqing Huo,Chaodong Wu +11 more
TL;DR: The mechanisms underlying BBR actions remain to be studied, but the beneficial effects of berberine on obesity-associated non-alcoholic fatty liver disease (NAFLD) and its role in NAFD is still unclear.